Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection

• Published in: Viruses Vol. 14; no. 7; p. 1547
• Main Authors: Schwab, Lara S. U, Villalón-Letelier, Fernando, Tessema, Melkamu B, Londrigan, Sarah L, Brooks, Andrew G, Hurt, Aeron, Coch, Christoph, Zillinger, Thomas, Hartmann, Gunther, Reading, Patrick C
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 15.07.2022; MDPI
• Subjects: Agonists; Analysis; Animal models; Animals; Care and treatment; Dengue fever; Diagnosis; Disease prevention; Fibroblasts; Immunocompromised host; Inbreeding; Infections; Influenza; Influenza A; innate immunity; Interferon; Intravenous administration; mouse model; Myxoma; Myxovirus resistance proteins; Prophylaxis; Proteins; RIG-I; RNA viruses; Rodents; Severe acute respiratory syndrome coronavirus 2; Transcription activation; Viruses; Australia; United States > US; Melbourne Victoria Australia
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v14071547

RIG-I is an innate sensor of RNA virus infection and its activation induces interferon-stimulated genes (ISGs). In vitro studies using human cells have demonstrated the ability of synthetic RIG-I agonists (3pRNA) to inhibit IAV replication. However, in mouse models of IAV the effectiveness of 3pRNA reported to date differs markedly between studies. Myxoma resistance (Mx)1 is an ISG protein which mediates potent anti-IAV activity, however most inbred mouse strains do not express a functional Mx1. Herein, we utilised C57BL/6 mice that do (B6.A2G-Mx1) and do not (B6-WT) express functional Mx1 to assess the ability of prophylactic 3pRNA treatment to induce ISGs and to protect against subsequent IAV infection. In vitro, 3pRNA treatment of primary lung cells from B6-WT and B6.A2G-Mx1 mice resulted in ISG induction however inhibition of IAV infection was more potent in cells from B6.A2G-Mx1 mice. In vivo, a single intravenous injection of 3pRNA resulted in ISG induction in lungs of both B6-WT and B6.A2G-Mx1 mice, however potent and long-lasting protection against subsequent IAV challenge was only observed in B6.A2G-Mx1 mice. Thus, despite broad ISG induction, expression of a functional Mx1 is critical for potent and long-lasting RIG-I agonist-mediated protection in the mouse model of IAV infection.